[Suprachoroidal haemorrhage and acute glaucoma associated with systemic fibrinolysis]

To describe the clinical case of a patient with acute myocardial infarction and an ocular haemorrhage as a complication of the use of systemic thrombolytic agents.

A patient who received therapy with tissue plasminogen activator for an acute myocardial infarction developed three hours later a massive suprachoroidal haemorrhage with secondary acute angle closure. In patients who have undergone systemic thrombolytic agents, the presence of loss of vision and pain must alert to the possibility of secondary ocular haemorrhage. These patients may benefit from continuous control (Arch Soc Esp Oftalmol 2002; 77: 459-462).